WARNER CHILCOTT PLC
8-K, 2000-07-21
PHARMACEUTICAL PREPARATIONS
Previous: MASTERPIECE TECHNOLOGY GROUP INC, S-8, EX-4, 2000-07-21
Next: WARNER CHILCOTT PLC, 8-K, EX-99.1, 2000-07-21



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                   FORM 8-K
                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



                                July 19, 2000
                DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)




                     WARNER CHILCOTT PUBLIC LIMITED COMPANY
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)






       IRELAND                         005-52501         NOT APPLICABLE
(STATE OR OTHER JURISDICTION       (COMMISSION FILE      (IRS EMPLOYER
OF INCORPORATION OR ORGANIZATION)      NUMBER)          IDENTIFICATION NO.)

                          LINCOLN HOUSE, LINCOLN PLACE,
                                DUBLIN 2,IRELAND
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)




                                 353-1-662-4962
                         (REGISTRANT'S TELEPHONE NUMBER,
                              INCLUDING AREA CODE)
<PAGE>   2

Item 5. Other Events

            As disclosed in the attached press release, the registrant's
co-promotion agreement with Schering-Plough will terminate on September 30,
2000.

            THIS CURRENT REPORT ON FORM 8-K CONTAINS OR INCORPORATES BY
REFERENCE FORWARD-LOOKING STATEMENTS THAT INVOLVE RISKS AND UNCERTAINTIES.
THESE STATEMENTS MAY DIFFER MATERIALLY FROM ACTUAL FUTURE EVENTS OR RESULTS.
READERS ARE REFERRED TO ALL DOCUMENTS FILED BY WARNER CHILCOTT WITH THE
SECURITIES AND EXCHANGE COMMISSION, WHICH IDENTIFY IMPORTANT RISK FACTORS THAT
COULD CAUSE ACTUAL RESULTS TO DIFFER FROM THOSE CONTAINED IN ANY
FORWARD-LOOKING STATEMENTS.

Item 7. Exbihits

            99.1 Press release of Warner Chilcott plc, dated July 19, 2000.





<PAGE>   3
                                   SIGNATURES

         PURSUANT TO THE REQUIREMENTS THE SECURITIES EXCHANGE ACT OF 1934, THE
REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE
UNDERSIGNED, HEREUNTO DULY AUTHORIZED.

                                    WARNER CHILCOTT PUBLIC LIMITED COMPANY

Date July 21, 2000               By: /s/      PAUL S. HERENDEEN
                                        ---------------------------------------
                                          Paul S. Herendeen
                                          Executive Vice President and Chief
                                          Financial Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission